Figure 3. Adjusted Odds of Receiving IV Alteplase (tPA) or EVT in Patients With a National Institutes of Health Stroke Scale (NIHSS) Score (n = 384,700), Shown for Models Without and With Adjustment for the NIHSS Score.

(A) IV alteplase (tissue plasminogen activator [tPA]). (B) endovascular thrombectomy (EVT). Model adjusted for patient age, sex, race/ethnicity, hospital Census region, hospital teaching status, hospital bed size, patient location, and median household income by patient zip code. Model in patients with an NIHSS is also adjusted for NIHSS.